Your browser doesn't support javascript.
loading
Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP].
Savard, Christian; Laliberté-Gagné, Marie-Ève; Babin, Cindy; Bolduc, Marilène; Guérin, Annie; Drouin, Karine; Forget, Marie-Andrée; Majeau, Nathalie; Lapointe, Réjean; Leclerc, Denis.
Affiliation
  • Savard C; Infectious Disease Research Centre, CHUL, Laval University, 2705 boul. Laurier, Quebec city, PQ, G1V 4G2, Canada.
Vaccine ; 30(15): 2535-42, 2012 Mar 28.
Article in En | MEDLINE | ID: mdl-22326774
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Core Proteins / Adjuvants, Immunologic / RNA-Binding Proteins / Potexvirus / Capsid Proteins / Nanoparticles Limits: Animals Language: En Journal: Vaccine Year: 2012 Document type: Article Affiliation country: Canada Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Core Proteins / Adjuvants, Immunologic / RNA-Binding Proteins / Potexvirus / Capsid Proteins / Nanoparticles Limits: Animals Language: En Journal: Vaccine Year: 2012 Document type: Article Affiliation country: Canada Country of publication: Netherlands